Luise Gaede1,2, Johannes Blumenstein1, Christoph Liebetrau3,4,5, Oliver Dörr4, Won-Keun Kim3,4,5, Holger Nef3,4,5, Oliver Husser1, Jan Gülker1, Albrecht Elsässer6, Christian W Hamm3,4,5, Stephan Achenbach2, Helge Möllmann7. 1. Department of Internal Medicine I, St. Johannes-Hospital Dortmund, Johannesstrasse 9-13, 44137, Dortmund, Germany. 2. Medizinische Klinik 2, Friedrich Alexander Universität Erlangen-Nürnberg, Erlangen, Germany. 3. Department of Cardiology, Kerckhoff Heart and Thorax Center, Bad Nauheim, Germany. 4. Medical Clinic I, Department of Cardiology and Angiology, University of Giessen, Giessen, Germany. 5. German Center for Cardiovascular Research (DZHK), Partner SITE RhineMain, Bad Nauheim, Germany. 6. Department of Cardiology, Klinikum Oldenburg, Oldenburg, Germany. 7. Department of Internal Medicine I, St. Johannes-Hospital Dortmund, Johannesstrasse 9-13, 44137, Dortmund, Germany. moellmann@me.com.
Abstract
BACKGROUND: Transcatheter aortic valve implantation (TAVI) is emerging as the standard of care for patients with severe aortic stenosis. Recent results have been favourable even for patients with low periprocedural risk. METHODS: We analysed the number of procedures, complications, and in-hospital mortality rates of all patients undergoing isolated aortic valve replacement in 2017 in Germany, focussing especially on transvascular (TV) TAVI. Patients were stratified according the German Aortic Valve Score (AKL) into the risk classes low, intermediate, high and very high (≥ 10%). RESULTS: A total of 17,956 TV-TAVI and 9011 isolated surgical aortic valve replacements (iSAVR) were performed in Germany in 2017. Although the total rate of intraprocedural complications after TV-TAVI was the same as in 2016 (both 7.4%), fewer patients experienced an arterial vascular complication in 2017 (2017: 6.0%; 2016: 7.1%; p < 0.001). Likewise, the rate of new pacemaker implantation decreased (2017: 9.6%; 2016:11.4%; p < 0.001). In-hospital mortality after TV-TAVI and iSAVR was equal (2.7%) in 2017, despite the much higher risk profile of TV-TAVI patients. Using the AKL score as reference, TV-TAVI showed a more favourable observed-to-expected mortality (O/E) ratio (0.89) than iSAVR (1.14)- even more pronounced in patients at low risk (0.81 vs. 1.14). CONCLUSIONS: The rates of major complications like bleeding and permanent pacemaker implantation after TV-TAVI keep declining. In 2017 patients undergoing TV-TAVI had a low in-hospital mortality rate with an O/E ratio < 1, indicating that the results were again better than those of all TAVI and SAVR of the previous year. Overall in-hospital mortality after transvascular TAVI and isolated aortic valve repair 2017 in Germany stratified to risk groups by the German Aortic Valve Score (German AV Score/AKL Score): low risk group (AKL 0- < 3%), intermediate risk group (AKL 3- < 6%), high risk group (AKL 6- < 10%) and very high risk group (AKL ≥ 10%).
BACKGROUND: Transcatheter aortic valve implantation (TAVI) is emerging as the standard of care for patients with severe aortic stenosis. Recent results have been favourable even for patients with low periprocedural risk. METHODS: We analysed the number of procedures, complications, and in-hospital mortality rates of all patients undergoing isolated aortic valve replacement in 2017 in Germany, focussing especially on transvascular (TV) TAVI. Patients were stratified according the German Aortic Valve Score (AKL) into the risk classes low, intermediate, high and very high (≥ 10%). RESULTS: A total of 17,956 TV-TAVI and 9011 isolated surgical aortic valve replacements (iSAVR) were performed in Germany in 2017. Although the total rate of intraprocedural complications after TV-TAVI was the same as in 2016 (both 7.4%), fewer patients experienced an arterial vascular complication in 2017 (2017: 6.0%; 2016: 7.1%; p < 0.001). Likewise, the rate of new pacemaker implantation decreased (2017: 9.6%; 2016:11.4%; p < 0.001). In-hospital mortality after TV-TAVI and iSAVR was equal (2.7%) in 2017, despite the much higher risk profile of TV-TAVI patients. Using the AKL score as reference, TV-TAVI showed a more favourable observed-to-expected mortality (O/E) ratio (0.89) than iSAVR (1.14)- even more pronounced in patients at low risk (0.81 vs. 1.14). CONCLUSIONS: The rates of major complications like bleeding and permanent pacemaker implantation after TV-TAVI keep declining. In 2017 patients undergoing TV-TAVI had a low in-hospital mortality rate with an O/E ratio < 1, indicating that the results were again better than those of all TAVI and SAVR of the previous year. Overall in-hospital mortality after transvascular TAVI and isolated aortic valve repair 2017 in Germany stratified to risk groups by the German Aortic Valve Score (German AV Score/AKL Score): low risk group (AKL 0- < 3%), intermediate risk group (AKL 3- < 6%), high risk group (AKL 6- < 10%) and very high risk group (AKL ≥ 10%).
Authors: Nicolas Werner; Ralf Zahn; Andreas Beckmann; Timm Bauer; Sabine Bleiziffer; Christian W Hamm; Raffi Berkeredjian; Alexander Berkowitsch; Friedrich W Mohr; Sandra Landwehr; Hugo A Katus; Wolfgang Harringer; Stephan Ensminger; Christian Frerker; Helge Möllmann; Thomas Walther; Steffen Schneider; Rüdiger Lange Journal: Circulation Date: 2018-12-04 Impact factor: 29.690
Authors: Alessandro Parolari; Lorenzo L Pesce; Matteo Trezzi; Laura Cavallotti; Samer Kassem; Claudia Loardi; Davide Pacini; Elena Tremoli; Francesco Alamanni Journal: Ann Thorac Surg Date: 2010-03 Impact factor: 4.330
Authors: Thomas Walther; Christian W Hamm; Gerhard Schuler; Alexander Berkowitsch; Joachim Kötting; Norman Mangner; Harald Mudra; Andreas Beckmann; Jochen Cremer; Armin Welz; Rüdiger Lange; Karl-Heinz Kuck; Friedrich W Mohr; Helge Möllmann Journal: J Am Coll Cardiol Date: 2015-03-15 Impact factor: 24.094
Authors: Michael J Mack; Martin B Leon; Craig R Smith; D Craig Miller; Jeffrey W Moses; E Murat Tuzcu; John G Webb; Pamela S Douglas; William N Anderson; Eugene H Blackstone; Susheel K Kodali; Raj R Makkar; Gregory P Fontana; Samir Kapadia; Joseph Bavaria; Rebecca T Hahn; Vinod H Thourani; Vasilis Babaliaros; Augusto Pichard; Howard C Herrmann; David L Brown; Mathew Williams; Jodi Akin; Michael J Davidson; Lars G Svensson Journal: Lancet Date: 2015-03-15 Impact factor: 79.321
Authors: Helmut Baumgartner; Volkmar Falk; Jeroen J Bax; Michele De Bonis; Christian Hamm; Per Johan Holm; Bernard Iung; Patrizio Lancellotti; Emmanuel Lansac; Daniel Rodriguez Muñoz; Raphael Rosenhek; Johan Sjögren; Pilar Tornos Mas; Alec Vahanian; Thomas Walther; Olaf Wendler; Stephan Windecker; Jose Luis Zamorano Journal: Eur Heart J Date: 2017-09-21 Impact factor: 29.983
Authors: Michael J Reardon; Nicolas M Van Mieghem; Jeffrey J Popma; Neal S Kleiman; Lars Søndergaard; Mubashir Mumtaz; David H Adams; G Michael Deeb; Brijeshwar Maini; Hemal Gada; Stanley Chetcuti; Thomas Gleason; John Heiser; Rüdiger Lange; William Merhi; Jae K Oh; Peter S Olsen; Nicolo Piazza; Mathew Williams; Stephan Windecker; Steven J Yakubov; Eberhard Grube; Raj Makkar; Joon S Lee; John Conte; Eric Vang; Hang Nguyen; Yanping Chang; Andrew S Mugglin; Patrick W J C Serruys; Arie P Kappetein Journal: N Engl J Med Date: 2017-03-17 Impact factor: 91.245
Authors: J F Gummert; A Funkat; B Osswald; A Beckmann; W Schiller; A Krian; F Beyersdorf; A Haverich; J Cremer Journal: Clin Res Cardiol Date: 2009-03-05 Impact factor: 5.460
Authors: Luise Gaede; Johannes Blumenstein; Christoph Liebetrau; Oliver Dörr; Won-Keun Kim; Holger Nef; Oliver Husser; Albrecht Elsässer; Christian W Hamm; Helge Möllmann Journal: Eur Heart J Date: 2018-02-21 Impact factor: 29.983
Authors: Helge Möllmann; Oliver Husser; Johannes Blumenstein; Christoph Liebetrau; Oliver Dörr; Won-Keun Kim; Holger Nef; Christian Tesche; Christian W Hamm; Albrecht Elsässer; Stephan Achenbach; Luise Gaede Journal: Clin Res Cardiol Date: 2019-10-01 Impact factor: 5.460
Authors: Victor Mauri; Maria I Körber; Elmar Kuhn; Tobias Schmidt; Christian Frerker; Thorsten Wahlers; Tanja K Rudolph; Stephan Baldus; Matti Adam; Henrik Ten Freyhaus Journal: Clin Res Cardiol Date: 2020-02-18 Impact factor: 5.460
Authors: Philipp Breitbart; Gregor Pache; Jan Minners; Manuel Hein; Holger Schröfel; Franz-Josef Neumann; Philipp Ruile Journal: Clin Res Cardiol Date: 2020-05-12 Impact factor: 5.460
Authors: Daniela Haase; Laura Bäz; Marcus Franz; P Christian Schulze; Tarek Bekfani; Sophie Neugebauer; Michael Kiehntopf; Sven Möbius-Winkler Journal: Clin Res Cardiol Date: 2020-10-14 Impact factor: 5.460
Authors: Niklas Schofer; Elke Jeschke; Janine Kröger; Henning Baberg; Volkmar Falk; Jan F Gummert; Christian W Hamm; Martin Möckel; Alina Goßling; Jürgen Malzahn; Christian Günster; Stefan Blankenberg Journal: Clin Res Cardiol Date: 2022-03-24 Impact factor: 6.138